Percutaneous 17ß-estradiol replacement therapy in hypertensive postmenopausal women
نویسندگان
چکیده
منابع مشابه
Percutaneous 17 beta-estradiol replacement therapy in hypertensive postmenopausal women.
The present study evaluated the short-term effects of percutaneous 17 beta-estradiol on blood pressure, metabolic profile and hormonal levels in postmenopausal women with systemic arterial hypertension. After a wash-out period of 15 days, 10 hypertensive patients were treated with guanabenz acetate to control blood pressure, followed by 17 beta-estradiol in the form of hydroalcoholic gel admini...
متن کاملEffects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women.
OBJECTIVE We observed that estrogen did not show cardioprotective benefits in type 2 diabetic postmenopausal women. We hypothesized that hypertensive and/or overweight women may be less likely to realize cardiovascular benefits from estrogen. METHODS AND RESULTS We administered micronized progesterone (MP) 100 mg or medroxyprogesterone acetate (MPA) 2.5 mg with conjugated equine estrogen (CEE...
متن کاملEffect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women.
OBJECTIVES This study was carried out to assess the effect of topical androgen replacement therapy on body weight, body composition and fat distribution in postmenopausal women. METHODS 39 healthy postmenopausal women (51.4 +/- 2.24 years), with increasing body weight, were prospectively studied for 6 months. Body composition (fat mass, kg, %) was measured by means of dual-energy X-ray absorp...
متن کاملDouble-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women.
We investigated the effects of transdermal 17beta-estradiol, combined with standard antihypertensive therapy, on the modification of the cardiovascular risk profile in hypertensive postmenopausal women. In a randomized, double-blind, placebo-controlled study, we enrolled 200 postmenopausal women with mild to moderate hypertension. Patients received 17beta-estradiol (50 microg/day, transdermal) ...
متن کاملSerum vitamin A status in women users of lowdose oral contraceptives and in postmenopausal women taking hormone replacement therapy.
Background: One of the most important nonenzymatic antioxidant defense systems is vitamin A, and is considered as an important dietary agent for reducing cardiovascular diseases. Objective: The objective of this study was to investigate the serum vitamin A status in women who used low-dose oral contraceptives (OCs) containing 0.15 mg levonorgestrol and 0.03 mg ethinyl estradiol and also in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Brazilian Journal of Medical and Biological Research
سال: 1997
ISSN: 0100-879X
DOI: 10.1590/s0100-879x1997000900001